People who are struggling to manage their type 1 diabetes are set to be offered new technology to help them control their condition with little human input.
In draft guidance, an independent NICE committee has recommended the use of hybrid closed loop systems for managing blood glucose levels in type 1 diabetes – technology that has been described as a step towards an artificial pancreas.
Cambridge scientists have successfully trialled an artificial pancreas for use by people living with type 2 diabetes.
The device – powered by an algorithm developed at the University of Cambridge – doubled the amount of time people were in the target range for glucose compared to standard treatment and halved the time spent experiencing high glucose levels.
Latest research shows that HbA1c screening in middle-aged adults can help diagnose diabetes two years faster than routine clinical care.
These findings show that HbA1c screening can prevent individuals living with undiagnosed diabetes.
The Diabetes Times has launched its first podcast series to explore key aspects of diabetes care by welcoming renowned academics and healthcare professionals working in the field.
Entitled ‘Talking Diabetes’, the new podcast will discuss the latest innovations, updates and news within the world of diabetes.
People living with type 1 diabetes with low glucose variability have a higher beta cell mass than those with high glucose variability, latest research shows.
During the study, a group of participants underwent a mixed-meal tolerance test to determine beta cell function and wore a blinded continuous glucose monitor for a week.
Hospital admissions for diabetes-related foot disease conditions and minor amputations are drastically on the rise, academics have said. To read more, click here.
Recruitment has opened for a trial screening programme for type 1 diabetes that could transform the way the condition is identified and managed in its earliest stages. To read more, click here.
The prevalence of cardiovascular risk factors was higher in people with diabetes compared to those living without the condition, a new research study has demonstrated. To read more, click here.
The combination of conventional treatment and beraprost sodium therapy delays the decline of estimated glomerular filtration rate in people with diabetic nephropathy in the long term. To read more, click here.
2023, and it's January. The perfect time for some crystal ball gazing, so why not give it a go? It's some personal speculation - yet laced with aims to achieve - and I have always enjoyed getting to the end of the year, then looking back to see where we got to. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Clinical Lead – Diabetes – Solent NHS Trust
Diabetes Specialist Nurse – University Hospital of North Midlands NHS Trust
Paediatric Diabetes Specialist Nurse – North Cumbria Integrated Care NHS Foundation Trust
Diabetic Eye Screener Grader – Nottingham University Hospitals NHS Trusts
With thanks to our sponsors
Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
